|
Market Cap (4-Jun) $11,471,000 (1,037th) |
Close (30-Jun) $0.070 |
Volume (30-Jun) 0 |
Shortsold (8-Jan) 4,400 (0.00%) (473rd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.04 |
RNO released this announcement to the ASX on 29 October 2021, 8:58. The announcement is marked as price sensitive, and is 10 page(s) in length and 401.16kb in size.
You can view all announcements from RNO and see how they appear on a price chart on the announcements page.
| Other Recent Announcements from RNO | |
|---|---|
| Change in substantial holding WG | 18 May 2023, 9:23 |
| App 3Y MJ | 4 May 2023, 10:56 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 28 April 2023, 9:19 |
| Quarterly Activities/Appendix 4C Cash Flow Report | 29 October 2021, 8:58 |
| Rhinoswab clinical trial approved at St Vincent's Hospital | 27 October 2021, 9:21 |
| Notice of Annual General Meeting/Proxy Form | 18 October 2021, 17:18 |
| Rhinomed Limited Audited Financial Report FY21 | 28 September 2021, 10:27 |
You must be logged in to post a reply.
